Top REF ratings and feedback for ISTM

Share |
REF2014 logo blue on white 465x150
Posted on 13 February 2015 exemplary strategic approach to impact...

Keele’s Research Institute for Science & Technology in Medicine has just received feedback on its results achieved in the UK Research Excellence Framework (REF2014).

ISTM's applied biomedical research impact "demonstrated an exemplary strategic approach to impact that is conducive to delivering future impacts of outstanding reach and significance."  The key highlights which most impressed the REF panels were case studies in cell therapy and clinical outcomes of patients with kidney failure, which were both judged "outstanding"

ISTM's submission in biomedical engineering research (to UoA15 General Engineering) was praised for its publication quality, specifically highlighting "the Biomagnetics and Nanomedicine research group had the highest proportion of outputs judged to be world-leading". ISTM's work in applied biomedical research (to Uoa3 Allied Health Professions) was also commended for research publication quality, the large majority of which were "judged to be internationally excellent or of world-leading quality in terms of originality, significance and rigour" and achieved "consistently high ratings [that] indicate strength in all areas of the submission"

Overall ISTM’s submissions in applied biomedical research (to UoA3 Allied Health Professions) achieved a 42% score in world-leading 4* rating, and ISTM’s biomedical engineering research (UoA15 General Engineering) doubled its world leading 4* score. Both units achieved ~90% across the top two ratings 4* and 3*.

The world-leading research environment in ISTM was evidenced by the REF awarding scores of 87.5% and 100% in top ratings 4* and 3* in the two UoAs. The panels commended ISTM's strong "research strategy, extensive international collaborations, with good evidence of a high quality staffing strategy and staff and research student development in line with the national Concordat." The panels also noted the Athena SWAN awards and HR Excellence in Research Award achieved recently. In biomedical engineering the panel commented that "research income has grown over the REF assessment period, with an impressive amount of EU funding, and there has been substantial investment in facilities. There is also strong evidence of collaboration and translational activity."